Regenesome Inc.
PrivateLast Round
Pre Seed
Aug 1, 2025
Total Funding Raised
$880,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Regenesome Inc. is a biotechnology company that develops anti-aging technology intended for supplements, foods and cosmetics that utilize exosomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Space Technology, Fashion & Beauty
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regenesome Inc. Comparables
Compare Regenesome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jung+ Longevity | 68% | |
| Elysium Health | 65% | |
| NOVOS | 63% |
Regenesome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 1, 2025 | ||||
| Debt | May 1, 2025 | ||||
| Pre Seed | Oct 21, 2024 |
Regenesome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leave a Nest Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 46% MoM.
- Apr 8, 2026
Monthly visitors increased 87% MoM.
Regenesome Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Regenesome Inc.'s valuation, stock price, and market status.
Is Regenesome Inc. a public or private company?
Regenesome Inc. is a private company.
What is the current stock price of Regenesome Inc.?
Regenesome Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Regenesome Inc. worth (valuation)?
Valuation information for Regenesome Inc. is not publicly available.
Can I buy Regenesome Inc. stock?
Regenesome Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Regenesome Inc.'s last funding round?
Regenesome Inc.'s most recent funding round was Pre Seed on August 1, 2025.
Who are the main investors in Regenesome Inc.?
Key investors in Regenesome Inc. include Leave a Nest Capital.
Will Regenesome Inc. IPO soon?
No public IPO plans have been announced for Regenesome Inc..
How can I track Regenesome Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Regenesome Inc.'s secondary market activity and sign up for updates.